Class and MOA Flashcards
What drugs are in the Alkylating Agents class?
Drugs in this class are:
- Cyclophosphamide
- lfosfamide
- Busulfan
- Melphalan
- Bendamustine
What is the class and MOA of Cyclophosphamide?
This drug in the following class:
- Alkylating Agents
This drug’s MOA is as follows:
- Alkylates and cross-links DNA preventing DNA synthesis and cell division
What is the class and MOA of lfosfamide?
This drug in the following class:
- Alkylating Agents
This drug’s MOA is as follows:
- Alkylates and cross-links DNA preventing DNA synthesis and cell division
What is the class and MOA of Busulfan?
This drug in the following class:
- Alkylating Agents
This drug’s MOA is as follows:
- Alkylates and cross-links DNA preventing DNA synthesis and cell division
What is the class and MOA of Melphalan?
This drug in the following class:
- Alkylating Agents
This drug’s MOA is as follows:
- Alkylates and cross-links DNA preventing DNA synthesis and cell division
What is the class and MOA of Bendamustine?
This drug in the following class:
- Alkylating Agents
This drug’s MOA is as follows:
- Alkylates and cross-links DNA preventing DNA synthesis and cell division
What drugs are in the Anti-Androgens class?
Drugs in this class are:
- Flutamide
- Abiraterone acetate
- Apalutamide
- Bicalutamide
- Enzalutamide
- Nilutamide
- Darolutamide
What is the class and MOA of Flutamide?
This drug in the following class:
- Anti-Androgens
This drug’s MOA is as follows:
- Non-steroidal anti-androgen that inhibits androgen uptake and inhibits binding of androgen in target tissues
What is the class and MOA of Abiraterone acetate?
This drug in the following class:
- Anti-Androgens
This drug’s MOA is as follows:
- Selectively and irreversibly inhibits CYP17 an enzyme required for biosynthesis and inhibits the formation of testosterone
What is the class and MOA of Apalutamide?
This drug in the following class:
- Anti-Androgens
This drug’s MOA is as follows:
- Nonsteroidal androgen receptor antagonist
What is the class and MOA of Bicalutamide?
This drug in the following class:
- Anti-Androgens
This drug’s MOA is as follows:
- Non-steroidal anti-androgen that inhibits androgen uptake and inhibits binding of androgen in target tissues
What is the class and MOA of Enzalutamide?
This drug in the following class:
- Anti-Androgens
This drug’s MOA is as follows:
- Pure androgen receptor signaling inhibitor
What is the class and MOA of Nilutamide?
This drug in the following class:
- Anti-Androgens
This drug’s MOA is as follows:
- Non-steroidal anti-androgen that inhibits androgen uptake and inhibits binding of androgen in target tissues
What is the class and MOA of Darolutamide?
This drug in the following class:
- Anti-Androgens
This drug’s MOA is as follows:
- Competitive androgen receptor inhibitor, also inhibits androgen receptor translocation and androgen receptor-mediated transcription
What drugs are in the VEGF Inhibitors class?
Drugs in this class are:
- Axitinib
- Cabozantinib
- Lenvatinib
- Vandetanib
- Pazopanib
- Regorafenib
- Sorafenib
- Sunitinib
What is the class and MOA of Axitinib?
This drug in the following class:
- VEGF Inhibitors
This drug’s MOA is as follows:
- Binds to VEGF and other endothelial growth factors receptors on endothelial cells blocking signals that promote the growth and survival of new blood vessels
What is the class and MOA of Cabozantinib?
This drug in the following class:
- VEGF Inhibitors
This drug’s MOA is as follows:
- Binds to VEGF and other endothelial growth factors receptors on endothelial cells blocking signals that promote the growth and survival of new blood vessels
What is the class and MOA of Lenvatinib?
This drug in the following class:
- VEGF Inhibitors
This drug’s MOA is as follows:
- Binds to VEGF and other endothelial growth factors receptors on endothelial cells blocking signals that promote the growth and survival of new blood vessels
What is the class and MOA of Vandetanib?
This drug in the following class:
- VEGF Inhibitors
This drug’s MOA is as follows:
- Binds to VEGF and other endothelial growth factors receptors on endothelial cells blocking signals that promote the growth and survival of new blood vessels
What is the class and MOA of Pazopanib?
This drug in the following class:
- VEGF Inhibitors
This drug’s MOA is as follows:
- Binds to VEGF and other endothelial growth factors receptors on endothelial cells blocking signals that promote the growth and survival of new blood vessels
What is the class and MOA of Regorafenib?
This drug in the following class:
- VEGF Inhibitors
This drug’s MOA is as follows:
- Binds to VEGF and other endothelial growth factors receptors on endothelial cells blocking signals that promote the growth and survival of new blood vessels
What is the class and MOA of Sorafenib?
This drug in the following class:
- VEGF Inhibitors
This drug’s MOA is as follows:
- Binds to VEGF and other endothelial growth factors receptors on endothelial cells blocking signals that promote the growth and survival of new blood vessels
What is the class and MOA of Sunitinib?
This drug in the following class:
- VEGF Inhibitors
This drug’s MOA is as follows:
- Binds to VEGF and other endothelial growth factors receptors on endothelial cells blocking signals that promote the growth and survival of new blood vessels
What drugs are in the EGFR Inhibitors class?
Drugs in this class are (not all inclusive):
- Gefitinib
- Erlotinib
- Osimertinib
- Afatinib
What is the class and MOA of Gefitinib?
This drug in the following class:
- EGFR Inhibitors
This drug’s MOA is as follows:
- EGFR inhibitors are highly selective tyrosine kinase inhibitors that covalently bind to epidermal growth factor receptors and irreversibly inhibit tyrosine kinase phosphorylation and downregulate EGFR signaling preventing cell growth.
What is the class and MOA of Erlotinib?
This drug in the following class:
- EGFR Inhibitors
This drug’s MOA is as follows:
- EGFR inhibitors are highly selective tyrosine kinase inhibitors that covalently bind to epidermal growth factor receptors and irreversibly inhibit tyrosine kinase phosphorylation and downregulate EGFR signaling preventing cell growth.
What is the class and MOA of Osimertinib?
This drug in the following class:
- EGFR Inhibitors
This drug’s MOA is as follows:
- EGFR inhibitors are highly selective tyrosine kinase inhibitors that covalently bind to epidermal growth factor receptors and irreversibly inhibit tyrosine kinase phosphorylation and downregulate EGFR signaling preventing cell growth.
What is the class and MOA of Afatinib?
This drug in the following class:
- EGFR Inhibitors
This drug’s MOA is as follows:
- EGFR inhibitors are highly selective tyrosine kinase inhibitors that covalently bind to epidermal growth factor receptors and irreversibly inhibit tyrosine kinase phosphorylation and downregulate EGFR signaling preventing cell growth.
What drugs are in the BRAF Inhibitors class?
Drugs in this class are:
- Dabrafenib
- Vemurafenib
- Encorafenib
What is the class and MOA of Dabrafenib?
This drug in the following class:
- BRAF Inhibitors
This drug’s MOA is as follows:
- Selectively targets mutated forms BRAF kinase (V600-) and interferes with the mitogen-activated protein kinase (MAPK) signaling pathway that regulates the proliferation and survival of melanoma cells.
What is the class and MOA of Vemurafenib?
This drug in the following class:
- BRAF Inhibitors
This drug’s MOA is as follows:
- Selectively targets mutated forms BRAF kinase (V600-) and interferes with the mitogen-activated protein kinase (MAPK) signaling pathway that regulates the proliferation and survival of melanoma cells.
What is the class and MOA of Encorafenib?
This drug in the following class:
- BRAF Inhibitors
This drug’s MOA is as follows:
- Selectively targets mutated forms BRAF kinase (V600-) and interferes with the mitogen-activated protein kinase (MAPK) signaling pathway that regulates the proliferation and survival of melanoma cells.
What drugs are in the BCR-ABL TKIs class?
Drugs in this class are:
- Bosutinib
- Dasatinib
- lmatinib
- Nilotinib
- Ponatinib
- Asciminib
What is the class and MOA of Bosutinib?
This drug in the following class:
- BCR-ABL TKIs
This drug’s MOA is as follows:
- Inhibits BCR-ABL tyrosine kinase - the abnormal gene product of the Philadelphia chromosome in chronic myeloid leukemia
What is the class and MOA of Dasatinib?
This drug in the following class:
- BCR-ABL TKIs
This drug’s MOA is as follows:
- Inhibits BCR-ABL tyrosine kinase - the abnormal gene product of the Philadelphia chromosome in chronic myeloid leukemia
What is the class and MOA of lmatinib?
This drug in the following class:
- BCR-ABL TKIs
This drug’s MOA is as follows:
- Inhibits BCR-ABL tyrosine kinase - the abnormal gene product of the Philadelphia chromosome in chronic myeloid leukemia
What is the class and MOA of Nilotinib?
This drug in the following class:
- BCR-ABL TKIs
This drug’s MOA is as follows:
- Inhibits BCR-ABL tyrosine kinase - the abnormal gene product of the Philadelphia chromosome in chronic myeloid leukemia
What is the class and MOA of Ponatinib?
This drug in the following class:
- BCR-ABL TKIs
This drug’s MOA is as follows:
- Inhibits BCR-ABL tyrosine kinase - the abnormal gene product of the Philadelphia chromosome in chronic myeloid leukemia
What is the class and MOA of Asciminib?
This drug in the following class:
- BCR-ABL TKIs
This drug’s MOA is as follows:
- Inhibits BCR-ABL tyrosine kinase - the abnormal gene product of the Philadelphia chromosome in chronic myeloid leukemia
- This drug is a novel first in class STAMP (Specifically Targeting the ASL Myristoyl Pocket) inhibitor. This drug potently inhibits ABL1 kinase activity of the BCR-ABL1 fusion protein via allosteric binding to the ASL myristoyl pocket.
What drugs are in the Somatostatin Analogs class?
Drugs in this class are:
- Octreotide
- Lanreotide
What is the class and MOA of Octreotide?
This drug in the following class:
- Somatostatin Analogs
This drug’s MOA is as follows:
- Mimics natural somatostatin by inhibiting serotonin release and the secretion of gastrin, VIP, insulin, glucagon, secretin, motilin, and pancreatic polypeptide
- Control symptoms that result from release of peptides and neuroamines from neuroendocrine tumors and help control the disease itself
What is the class and MOA of Lanreotide?
This drug in the following class:
- Somatostatin Analogs
This drug’s MOA is as follows:
- Mimics natural somatostatin by inhibiting serotonin release and the secretion of gastrin, VIP, insulin, glucagon, secretin, motilin, and pancreatic polypeptide
- Control symptoms that result from release of peptides and neuroamines from neuroendocrine tumors and help control the disease itself
What is the MOA of Tretinoin?
This drug’s MOA is as follows:
- Binds one or more nuclear receptors and decreases proliferation and induces differentiation of APL cells
What is the MOA of Arsenic Trioxide?
This drug’s MOA is as follows:
- Induces apoptosis in APL cells via DNA fragmentation and damages the fusion protein: promyelocytic leukemia (PML)-retinoic acid receptor (RAR) alpha
What is the MOA of Hydroxyurea?
This drug’s MOA is as follows:
- Antimetabolite that selectively inhibits ribonucleoside diphosphate reductase and interferes with DNA repair.
- In sickle cell anemia, this drug increases hemoglobin F levels.
What is the general MOA of the Monoclonal Antibodies class?
The MOA of this drug class is as follows:
- Bind to specific targets (immune cells. cell receptors. tumor molecules. etc.) to exert anti-tumor effects, the specific target varies per antibody.
- This leads to very specific anti-tumor effects using biologic agents.
What drugs are in the Anti-PD-1 class?
Drugs in this class are:
- Nivolumab
- Pembrolizumab
- Cemiplimab
- Dostarlimab
- Retifanlimab
- Nivolumab+Relatlimab
What drugs are in the Anti-PD-L1 class?
Drugs in this class are:
- Atezolizumab
- Avelumab
- Durvalumab
What drugs are in the Anti-CTLA4?
Drugs in this class are:
- lpilimumab
- Tremelimumab
What is the class and MOA of Nivolumab?
This drug in the following class:
- Immunotherapy - Anti-PD-1
This drug’s MOA is as follows:
- Immune checkpoint inhibitors remove inhibitory signals of T-cell activation, which enables tumor- reactive T-cells to overcome regulatory mechanisms and mount an effective antitumor response.